www.trustedrxapproved.net

Your reliable supplier of generic medications.

Check yourbonu$
Site search:
Obvious advantage Tell a friend and get discount! Want to give it a try?
Categories list

Generic Moxifloxacin - Avelox

Search by letter:ABCDEFGHIJKLMNOPQRSTUVWXYZ
Avelox

Generic Avelox

Moxifloxacin 400mg

Generic Avelox is an antibiotic in the class of drugs called fluoroquinolones. It is used to treat bacterial infections.
More info »

$15.00 Buy now!
Language/Idioma/Sprache:
Social bookmarks:
Testimonials

I received a partial shipment yesterday.
The pills have always worked very well...as expected.
That's why I ordered from you again this year...just like last year.
In fact, yours work better than the 50 mg brand name pills I still have!!
An since your pills are scored (unlike the brand name ones that I have to use a knife to split), I can easily lower the dosage to 25 mg...which is all I need.
Thank you for a great product at a reasonable price!

Our billing is certified by:

Secure shopping certificates


Special Offer!

News

  • Combo Drugs Not Effective for Blood Stream Infection - dailyRx

    Combo Drugs Not Effective for Blood Stream InfectiondailyRxDuring the randomized clinical trial 298 patients with severe sepsis or septic shock received antibiotic meropenem (Merrem), while 302 sepsis or septic shock patients were assigned to receive a combination therapy of meropenem and moxifloxacin (Avelox .

  • Combination therapy does not reduce mortality rates associated with severe sepsis - News-Medical.net

    Combination therapy does not reduce mortality rates associated with severe sepsisNews-Medical.

  • Indians popping more antibiotics than ever: Study - Times of India

    Indians popping more antibiotics than ever: StudyTimes of IndiaPart A included drugs like Moxifloxacin, Meropenem, Imipenem, Ertapenem, Doripenem, Colistin, Linezolid and Cefpirome.

  • 6 Cataract Safety Tips - OutpatientSurgery.net

    6 Cataract Safety TipsOutpatientSurgery.

  • MAXSEP-Studie: Kombinationstherapie bringt keinen Vorteil - innovations report

    MAXSEP-Studie: Kombinationstherapie bringt keinen Vorteilinnovations report302 Patienten eine Kombinationstherapie mit Meropenem plus Moxifloxacin.

bookmark Bookmark this site
Subscribe to the News
Trusted. Rx approved.